| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |